Successive researches and experiments have been conducted with the hope of producing a long-lasting solution to cancer and aging. Many experiments have failed. Some oncologists have given up while some have opted to try it later. However, there is one oncologist who never gave up despite all the challenges and has dedicated his efforts to getting a solution to the aging menace. Mikhail Blagosklonny, a prominent oncologist, has finally deduced a formula of the age suppressive treatment, which many had failed at.
With the new aging-suppressing method, individuals can use the non-genotoxic compound in therapeutic commodities to suppress the cellular hypertrophy. Mikhail Blagosklonny, cancer and aging researcher, has been deeply involved in developing cancer drugs as well as anti-aging drugs over the years. The success was not merely a one-day journey but a long one that combines piles of extensive researches and continued collaboration with other certified oncologists. Follow Mikhail on Google Scholar
Mikhail holds an M.D. and a Ph.D. in Internal Medicine and Experimental Medicine respectively from the First Pavlov State University of Medicine. In 2002, he got appointed as the Professor of Medicine at New York Medical College. After three years in practice, he got another appointment as the Senior Scientist dealing with cancer at Ordway Research Institute. After years of hard work and dedication, Mikhail received yet another appointment as a Professor of Oncology and was in charge of the Oncology Department at Roswell Park Institute, which also participates in cancer research.
He has been an advocate for rapamycin, which contains immune-suppressant functions that reduce chances of the body rejecting transplant organs like liver and kidney. He also formulated his hypothesis on TOR signaling in aging and cancer treatment. Besides, he has contributed immensely in lots of research that have borne the fruits through a practical remedy to cancer and aging.
Other than being a dedicated oncologist, Mikhail Blagosklonny also participates in publishing articles on cancer and related medical fields. He acts as the Chief Editor and has published more than 70 scientific publications and holds over 15 patents. Mikhail has dedicated his life to ensuring that people living with cancer get a cure. He says that his dream is to see the cancer patients receiving effective treatment with the great hope of getting better. Visit classroomvoices.org to read more about Mikhail.